FIRST TRUST ADVISORS LP

Position in NVCR — NovoCure Ltd

CIK 1125816 Wheaton, IL

Position in NVCR

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$1,027,793

+$143,161 QoQ

Shares Held

94,293

+37.7% QoQ

Ownership

0.081%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

FIRST TRUST ADVISORS LP holds $876,889,879 across 34 Medical Devices names. NVCR ranks #26 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	4,179,722	$429,132,057
2	MDT	Medtronic plc	883,289	$76,536,991
3	DXCM	Dexcom Inc	958,632	$60,202,089
4	BRKR	Bruker Corp	1,493,053	$53,929,074
5	ZBH	Zimmer Biomet Holdings, Inc.	387,537	$35,041,095
6	GEHC	GE HealthCare Technologies Inc.	440,549	$31,358,277
7	EW	Edwards Lifesciences Corp	352,315	$28,213,384
8	GMED	Globus Medical Inc	299,924	$25,841,451

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,027,793	94,293	+37.7%	Shares	Sole	2026-05-13
2025-09-30	$884,632	68,470	-55.0%	Shares	Sole	2025-11-12
2025-06-30	$2,710,459	152,273	+93.6%	Shares	Sole	2025-08-13
2022-12-31	$5,768,170	78,639	+1046.8%	Shares	Sole	2023-02-09
2022-09-30	$520,994	6,857	-75.0%	Shares	Sole	2022-11-14
2021-12-31	$2,061,321	27,455	-88.5%	Shares	Sole	2022-02-08
2021-09-30	$27,811,446	239,403	+188.9%	Shares	Sole	2021-11-15
2021-06-30	$18,380,448	82,862	-57.5%	Shares	Sole	2021-10-12
2021-03-31	$25,745,491	194,776	-27.5%	Shares	Sole	2021-05-14
2020-12-31	$46,462,624	268,508	+513.8%	Shares	Sole	2021-02-02
2020-06-30	$2,594,019	43,744	-33.7%	Shares	Sole	2020-07-22
2020-03-31	$4,443,901	65,992	—	Shares	Sole	2020-05-06
No filing history on record for this holder in this stock.